| 000 | 01472 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250518024846.0 | ||
| 264 | 0 | _c20200210 | |
| 008 | 202002s 0 0 eng d | ||
| 022 | _a2374-2445 | ||
| 024 | 7 |
_a10.1001/jamaoncol.2018.7002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFeit, Noah Z | |
| 245 | 0 | 0 |
_aUse, Safety, and Efficacy of Single-Patient Use of the US Food and Drug Administration Expanded Access Program. _h[electronic resource] |
| 260 |
_bJAMA oncology _cApr 2019 |
||
| 300 |
_a570-572 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aCompassionate Use Trials _xstatistics & numerical data |
| 650 | 0 | 4 |
_aDrugs, Investigational _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aProgram Evaluation |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aUnited States Food and Drug Administration |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aGoldman, Debra A | |
| 700 | 1 | _aSmith, Evan | |
| 700 | 1 | _aDeighan, Jenny | |
| 700 | 1 | _aIasonos, Alexia | |
| 700 | 1 | _aZivanovic, Oliver | |
| 700 | 1 | _aHyman, David M | |
| 773 | 0 |
_tJAMA oncology _gvol. 5 _gno. 4 _gp. 570-572 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/jamaoncol.2018.7002 _zAvailable from publisher's website |
| 999 |
_c29424260 _d29424260 |
||